| Literature DB >> 34097210 |
Motlagabo Gladys Matseke1,2, Robert A C Ruiter3, Violeta J Rodriguez4,5, Karl Peltzer6,7,8, Deborah L Jones5, Sibusiso Sifunda6.
Abstract
Male partner involvement (MPI) during the prenatal and postnatal periods has been proven to have a beneficial effect on infant development. Infants born to HIV seropositive mothers with lacking or no prenatal and postnatal male partner support may be at a higher risk for adverse developmental outcomes. This study examined the effect of MPI on cognitive, communicative, fine, and gross motor development in 160 infants born to HIV seropositive mothers attending Prevention of Mother-to-Child Transmission of HIV (PMTCT) services in rural South Africa. Results of the bivariate logistic regression showed that both prenatal (OR 1.13; 95% CI 1.01, 1.26; p < 0.05) and postnatal MPI (at 12 months) (1.19; 1.07, 1.31; p < 0.005) were associated with risk for delayed gross motor development in HIV exposed infants. Decreased postnatal MPI (0.85; 0.75, 0.98; p < 0.05) was significantly associated with risk for delayed cognitive development. Not living together with a male partner (2.01; 1.06, 3.80; p < 0.05) was significantly associated with risk for delayed cognitive development. In the multivariate logistic regression analysis, decreased postnatal MPI (0.85; 0.75, 0.98; p < 0.05) was significantly associated with risk for delayed cognitive development. On the other hand, postnatal MPI (1.30; 1.12, 1.50; p < 0.005) was associated with risk for delayed gross motor development among HIV exposed infants. Increased MPI can have beneficial effects on infants' cognitive development. Interventions in PMTCT programs should promote increased prenatal and postnatal MPI to improve cognitive development in HIV exposed infants.Entities:
Keywords: HIV-exposed infants; Infant development; Male partner involvement; Rural South Africa
Mesh:
Year: 2021 PMID: 34097210 PMCID: PMC8373750 DOI: 10.1007/s10461-021-03326-5
Source DB: PubMed Journal: AIDS Behav ISSN: 1090-7165
Demographic and psychosocial characteristics of infant-mother dyad participants (N = 160)
| Characteristic | Mean (SD) N (%) |
|---|---|
| Mother | |
| Age | 28.96 (5.58) |
| Educational attainment | |
| Grade 0–11 | 47 (68.4%) |
| Grade 12 or more | 22 (31.6%) |
| Monthly household income (rand) | |
| < 999 (~ $76) | 47 (68.4%) |
| 1000 or more | 22 (31.6%) |
| Relationship Status | |
| Unmarried, living separately | 81 (52.3%) |
| Unmarried, living together | 45 (29.0%) |
| Married | 29 (18.7%) |
| Months since HIV diagnosis | 26.2 (38.12) |
| Disclosure of serostatus to male partner (at 12 months postnatal) | |
| No | 60 (50.0%) |
| Yes | 60 (50.0%) |
| Male involvement, baseline (index) | 7.08 (3.02) |
| Male involvement, at 12 months (index) | 6.38 (3.46) |
| Infants | |
| Age | 13.94 (3.01) |
| Infant development (Bayley’s scale) scores | |
| Cognitive | 2.45 (0.69) |
| Receptive communication | 2.46 (0.76) |
| Expressive communication | 2.28 (0.76) |
| Fine motor | 2.38 (0.70) |
| Gross motor | 2.23 (0.77) |
Male partner involvement and infant development at 12 months (N = 160)
| Items | N (%) |
|---|---|
| Cognitive | |
| At risk | 18 (11.3) |
| Emerging risk | 52 (32.5) |
| Competent | 90 (56.3) |
| Receptive communication | |
| At risk | 29 (18.2) |
| Emerging risk | 56 (35.2) |
| Competent | 74 (46.5) |
| Expressive communication | |
| At risk | 20 (12.6) |
| Emerging risk | 59 (37.1) |
| Competent | 80 (50.3) |
| Fine motor development | |
| At risk | 20 (12.6) |
| Emerging risk | 59 (37.1) |
| Competent | 80 (50.3) |
| Male partner involvement (prenatal | |
| Male partner attends antenatal care visits with you | 42 (27.1) |
| Male partner knows your antenatal appointment time | 115 (74.2) |
| Discussed antenatal HIV prevention for your baby with your male partner | 103 (66.5) |
| Male partner supports your antenatal visits financially | 131 (84.5) |
| Male partner knows what happens in the antenatal clinic | 92 (59.4) |
| After testing for HIV, partner asked to take an HIV test | 108 (69.7) |
| Told partner that you were told to take ARV drugs (HIV medication) | 104 (67.1) |
| Discussed feeding options for your baby with your male partner | 107 (70.3) |
| Discussed the place of delivery for the baby with your male partner | 96 (61.9) |
| Discussed testing your baby for HIV with your male partner | 82 (52.9) |
| Discussed condom use with your male partner | 116 (74.8) |
| Male partner involvement (postnatal | |
| Male partner attends infant care visits with you | 70 (44.3) |
| Male partner knows your infant care appointment time | 113 (71.5) |
| Discussed HIV prevention for your baby with your male partner | 99 (62.7) |
| Male partner supports your infant care visits financially | 125 (79.1) |
| Male partner knows what happens in the infant care clinic | 84 (53.2) |
| After tested for HIV, male partner was asked to take an HIV test | 96 (60.8) |
| Told partner that you were told to take ARV drugs (HIV medication) | 110 (69.6) |
| Discuss feeding options for your baby with your male partner | 100 (63.3) |
| Discussed testing your baby for HIV with your male partner | 100 (63.3) |
| Discussed condom use with your male partner | 111 (70.3) |
Unadjusted logistic regression models predicting risk for delayed cognitive, expressive communication, receptive communication, and fine and gross motor development (N = 160)
| Predictor | Cognitive OR (95% CI) | Receptive communication OR (95% CI) | Expressive communication OR (95% CI) | Fine motor OR (95% CI) | Gross motor OR (95% CI) |
|---|---|---|---|---|---|
| Unmarried, not living together (ref = married or unmarried, living together) | 2.01 (1.06, 3.80)* | 1.11 (0.58, 2.10) | 1.27 (0.68, 2.39) | 1.19 (0.64, 2.23) | 1.21 (0.64, 2.39) |
| Household income (ref = below the poverty level, < 600) | 0.93 (0.49, 1.74) | 1.24 (0.65, 2.36) | 1.70 (0.90, 3.20) | 0.80 (0.43, 1.50) | 1.07 (0.57, 2.01) |
| Number of children (ref = no children) | 0.70 (0.31, 1.58) | 1.83 (0.82, 4.07) | 1.65 (0.73, 3.74) | 1.67 (0.75, 3.75) | 1.60 (0.69, 3.71) |
| Disclosure to partner at baseline (ref = not disclosed) | 1.44 (0.75, 2.75) | 0.97 (0.50, 1.89) | 1.11 (0.58, 2.13) | 1.37 (0.72, 2.64) | 1.86 (0.95, 3.65) |
| Disclosure to partner at 12-months (ref = not disclosed) | 0.58 (0.28, 1.20) | 0.93 (0.45, 1.93) | 0.90 (0.43, 1.86) | 0.84 (0.41, 1.73) | 0.70 (0.34, 1.47) |
| Baseline MPI | 0.96 (0.87, 1.07) | 0.97 (0.87, 1.08) | 0.97 (0.88, 1.08) | 1.08 (0.97, 1.20) | 1.13 (1.01, 1.26)* |
| 12-month MPI | 0.88 (0.80, 0.97)* | 0.94 (0.85, 1.03) | 1.07 (0.98, 1.17) | 1.05 (0.96, 1.15) | 1.19 (1.07, 1.31)** |
*p < 0.05, **p < 0.01, ***p < 0.001
Adjusted logistic regression models predicting risk for delayed cognitive, expressive communication, receptive communication, and fine and gross motor development (N = 160)
| Predictor | Cognitivea OR (95% CI) | Receptive communicationb OR (95% CI) | Expressive communicationc OR (95% CI) | Fine motord OR (95% CI) | Gross motore OR (95% CI) |
|---|---|---|---|---|---|
| Unmarried, not living together (ref = married or unmarried, living together) | 0.61 (0.26, 1.45) | 0.91 (0.39, 2.11) | 0.68 (0.29, 1.63) | 0.58 (0.25, 1.37) | 0.58 (0.23, 1.50) |
| Household income (ref = below the poverty level, < 600) | 0.89 (0.39, 2.00) | 0.92 (0.42, 2.01) | 1.92 (0.86, 4.30) | 0.79 (0.36, 1.74) | 0.87 (0.36, 2.10) |
| Number of children (ref = no children) | 0.68 (0.24, 1.92) | 1.23 (0.47, 3.20) | 1.31 (0.50, 3.49) | 1.68 (0.62, 4.52) | 1.58 (0.52, 4.80) |
| Disclosure to partner at baseline (ref = not disclosed) | 2.53 (0.95, 6.75) | 1.03 (0.41, 2.58) | 1.35 (0.53, 3.47) | 0.99 (0.40, 2.49) | 1.24 (0.45, 3.34) |
| Disclosure to partner at 12-months (ref = not disclosed) | 1.04 (0.41, 2.61) | 1.39 (0.57, 3.39) | 0.63 (0.25, 1.56) | 0.64 (0.26, 1.60) | 0.21 (0.07, 0.61)** |
| Baseline MPI | 0.95 (0.81, 1.11) | 0.96 (0.82, 1.12) | 0.96 (0.82, 1.12) | 1.04 (0.89, 1.21) | 1.08 (0.91, 1.29) |
| 12-month MPI | 0.85 (0.75, 0.98)* | 0.93 (0.82, 1.05) | 1.12 (0.98, 1.27) | 1.10 (0.97, 1.24) | 1.30 (1.12, 1.50)** |
*p < 0.05, **p < 0.01, ***p < 0.001
aHosmer and Lemeshow χ2 = 6.48, p = 0.594; Nagelkerke R2 = 0.162
bHosmer and Lemeshow χ2 = 14.50, p = 0.070; Nagelkerke R2 = 0.032
cHosmer and Lemeshow χ2 = 13.25, p = 0.104; Nagelkerke R2 = 0.071
dHosmer and Lemeshow χ2 = 5.93, p = 0.655; Nagelkerke R2 = 0.053
eHosmer and Lemeshow χ2 = 6.00, p = 0.647; Nagelkerke R2 = 0.214